nserc supports over 11,000 world-class researchers across canada, and we fund their research collaborations with over 4,000 companies. in response to the covid-19 pandemic, nserc is leveraging the expertise of researchers in natural science and engineering and their partners across canada to address this unprecedented crisis.

nserc is providing up to $15 million in total support to stimulate collaborations between academic researchers and the public and not-for-profit sectors, and industry to address pandemic-related research and technical challenges. support for up to $50,000 for one-year projects is being made available immediately.

nserc will process these applications in an accelerated fashion. partners do not need to provide cash contributions to participate, but must be engaged throughout the research process, from input in design to using the expertise and/or the research results.

the harrington scholar-innovator award recognizes physician-scientist innovators throughout the us and canada, whose research has the potential to change standard of care. the scholar-innovator award provides research and drug development support to help bridge the gap between basic discovery and the clinical realm.

up to twelve harrington scholar-innovator awards are made each year through a competitive selection process.

the fiscal year 2020 (fy20) defense appropriations bill has not been signed into law.  although fy20 funds have not been appropriated for the department of defense ovarian cancer research program (ocrp), the ocrp is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated fy20 funding opportunities. this pre-announcement should not be construed as an obligation by the government.

the fy20 defense appropriations act is anticipated to provide funding to the department of defense (dod) ovarian cancer research program (ocrp) to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of service members, veterans, retirees, their family members, and all women impacted by this disease.  as directed by the office of the assistant secretary of defense for health affairs, the defense health agency j9, research and development directorate manages the defense health program (dhp) research, development, test, and evaluation (rdt&e) appropriation.  the managing agent for the anticipated program announcements/funding opportunities is the congressionally directed medical research programs (cdmrp) at the u.s. army medical research and development command (usamrdc).

fy20 ocrp program announcements and general application instructions for the following award mechanism is posted on the grants.gov website. 

https://cdmrp.army.mil/funding/ocrp

proteogenomics research award – letter of intent due july 16, 2020

investigators at or above the postdoctoral level (or equivalent).

• supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer.
• the proposed research question should be innovative and have the potential to make an impact on ovarian cancer.
• the analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged.
• the use of the unique proteomics resource at the women’s health integrated research center clinical proteomics platform through the department of defense intramural gynecologic cancer center of excellence is encouraged.
• preliminary data are not required but allowed.
• clinical trials are not allowed.
• submission of a letter of intent (loi) is required prior to full application submission.
  • maximum funding of $250,000 for direct costs (plus indirect costs)
  • maximum period of performance is 2 years.

a pre-application is required and must be submitted through the electronic biomedical research application portal (ebrap) at https://ebrap.org prior to the pre-application deadline.  all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website.  the application package containing the required forms for each award mechanism will also be found on grants.gov.  a listing of all cdmrp and other usamrdc extramural funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420. 

for email notification when program announcements are released, subscribe to program-specific news and updates under “email subscriptions” on the ebrap homepage at https://ebrap.org.  for more information about the ocrp or other cdmrp-administered programs, please visit the cdmrp website (https://cdmrp.army.mil).

point of contact:

cdmrp help desk
301-682-5507
help@ebrap.org

canada is a world leader in medical education scholarship, with achievements including problem-based learning (pbl), multiple mini-interviews (mmis), and the first national licensure objective structured clinical examination (osce). medical 世界杯2022赛程表淘汰赛 are in a unique position to contribute to the medical education literature. our personal experiences with the training curricula can shed light on what works and what doesn't, generating ideas and stimulating new research questions.

the ontario medical 世界杯2022赛程表淘汰赛 association (omsa) is excited to announce the sixth annual medical student education research grant (mserg) call for applications in partnership with the associated medical services (ams), oma insurance, the cma, and md financial management.

the 2020 mserg will provide grants valued at $5,000 each to fund nine projects designed by ontario medical 世界杯2022赛程表淘汰赛 . this will enable 世界杯2022赛程表淘汰赛 to conduct research projects in medical education. three of these nine awards will be granted in the open stream and six of these nine awards will be granted in the compassionate care steam. of the nine mserg awards, at least one award will go to a student project from each of the six ontario medical schools, provided that they meet the eligibility criteria.

the deadline to apply is april 13th, 2020.

the law foundation of ontario invites applications to apply for a measuring impacts and progress 2020 grant, through our strategic granting program.

the purpose of the measuring impacts and progress 2020 granting is to build the knowledge that will improve justice system services for the people of ontario. the first method is to support research or activities that address making improvements in the use of data in the justice system. the second is to support empirical research that will help improve how the justice system serves the people of ontario. this granting stream highlights the foundation’s objective of expanding knowledge: “we continually deepen our knowledge of access to justice, including the contribution of community organizations. we are committed to share our knowledge of what is happening and what works”.

the canadian frailty network (cfn) is looking to fund proposals aimed at investigating the interaction between frailty and covid-19. older adults living with frailty are the most vulnerable to covid-19. as a result, cfn is looking for health, social or policy research studies that investigate determinants of increased susceptibility, and solutions to mitigate or prevent the differential risk to covid-19. see below for specific proposal details.

the nih exploratory/developmental grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. these studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

the nih small research grant program supports small research projects that can be carried out in a short period of time with limited resources. this program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

this funding opportunity announcement does not accept applications proposing clinical trial(s).